WEST PHARMACEUTICAL SERVICES INC Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
West Pharmaceutical Services Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • West Pharmaceutical Services Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.2M, a 67% decline year-over-year.
  • West Pharmaceutical Services Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $17.6M, a 28.5% increase year-over-year.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2023 was $22M.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2022 was -$54.1M, a 1491% decline from 2021.
  • West Pharmaceutical Services Inc annual Nonoperating Income (Expense) for 2021 was -$3.4M, a 39.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $22M +$76.1M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$54.1M -$50.7M -1491% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$3.4M +$2.2M +39.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$5.6M -$800K -16.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$4.8M -$5.2M -1300% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $400K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.